Effect of carvedilol on the production of reactive oxygen species by HL-60 cells
Language English Country Sweden Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
18987604
PII: NEL290508A18
Knihovny.cz E-resources
- MeSH
- Adenosine Triphosphate metabolism MeSH
- Adrenergic beta-Antagonists pharmacology toxicity MeSH
- Cell Differentiation drug effects MeSH
- Phagocytes drug effects MeSH
- Fluorometry MeSH
- Granulocytes drug effects MeSH
- HL-60 Cells MeSH
- Carbazoles pharmacology toxicity MeSH
- Carvedilol MeSH
- Humans MeSH
- Luminescence MeSH
- Nitric Oxide metabolism MeSH
- Peroxides metabolism MeSH
- Cell Proliferation drug effects MeSH
- Propanolamines pharmacology toxicity MeSH
- Reactive Oxygen Species metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Adenosine Triphosphate MeSH
- Adrenergic beta-Antagonists MeSH
- Carbazoles MeSH
- Carvedilol MeSH
- Nitric Oxide MeSH
- Peroxides MeSH
- Propanolamines MeSH
- Reactive Oxygen Species MeSH
OBJECTIVES: The generation of reactive oxygen species (ROS) by phagocytes is one of the irreplaceable microbicidal tools of innate immunity. It has been reported in our previous studies that short-term treatment by carvedilol ex vivo inhibits ROS generation. The purpose of this study was to investigate the long-term effect of carvedilol on phagocytes. METHODS: Human leukemia HL-60 cells differentiated into granulocyte-like cells were used as the model. Final concentrations of carvedilol were 0.1-100 micromol/l. The production of ROS by HL-60 cells was measured using luminol-enhanced chemiluminescence (CL). RESULTS: Carvedilol in concentrations 0.1-10 micromol/l did not exhibit any toxic effect on cells (measured using bioluminescent bacteria Photorhabdus luminescens subsp. thracensis). One hour's treatment with 10 micromol/l carvedilol significantly decreased both spontaneous and activated CL of cells. Conversely, no inhibitory effects on CL were observed in 10 micromol/l carvedilol after 48 h incubation; lower concentrations of carvedilol even slightly increased the CL activity of HL-60 cells. A significant increase in spontaneous CL activity was detected in cells incubated with 10 micromol/l carvedilol in comparison with the control. Powerful antioxidative properties of carvedilol against peroxyl radical (ORAC assay) were proved. No scavenging of nitric oxide (electrochemical method) was observed. CONCLUSIONS: Long-term influence of carvedilol can induce an increase in the generation of phagocyte-derived ROS and potentially also other inflammatory mediators. The increased ROS production is compensated for by antioxidative properties of carvedilol although the increased production of inflammatory mediators could affect the proper function of immune system.